HEAD & NECK CANCERS

Latest News

New Immunotherapy Combination Effective in Head and Neck Cancer
New Immunotherapy Combination Effective in Head and Neck Cancer

July 12th 2024

A new immunotherapy combination of eftilagimod alpha and pembrolizumab shows promise in treating head and neck squamous cell carcinoma, even in patients with low PD-L1 expression.

Petosemtamab and Pembrolizumab: A Promising Pair in HNSCC Treatment
Petosemtamab and Pembrolizumab: A Promising Pair in HNSCC Treatment

July 2nd 2024

Atezolizumab Falls Short in High-Risk HNSCC
Atezolizumab Falls Short in High-Risk HNSCC

June 17th 2024

Petosemtamab With Pembrolizumab Generates Early Clinical Efficacy in Select HNSCC
Petosemtamab With Pembrolizumab Generates Early Clinical Efficacy in Select HNSCC

June 4th 2024

Perioperative Chemo With FLOT Improves OS in Resectable Esophageal Cancer
Perioperative Chemo With FLOT Improves OS in Resectable Esophageal Cancer

June 3rd 2024

More News